Computational Analysis of SOD1-G93A Mouse Muscle Biomarkers for Comprehensive Assessment of ALS Progression
- PMID: 40164574
- DOI: 10.1111/nan.70014
Computational Analysis of SOD1-G93A Mouse Muscle Biomarkers for Comprehensive Assessment of ALS Progression
Abstract
Aims: To identify potential image biomarkers of neuromuscular disease by analysing morphological and network-derived features in skeletal muscle biopsies from a murine model of amyotrophic lateral sclerosis (ALS), the SOD1G93A mouse and wild-type (WT) controls at distinct stages of disease progression.
Methods: Using the NDICIA computational framework, we quantitatively evaluated histological differences between skeletal muscle biopsies from SOD1G93A and WT mice. The process involved the selection of a subset of features revealing these differences. A subset of discriminative features was selected to characterise these differences, and their temporal dynamics were assessed across disease stages.
Results: Our findings demonstrate that muscle pathology in the mutant model evolves from early alterations in muscle fibre arrangement, detectable at the presymptomatic stage through graph theory features, to the subsequent development of the typical morphological pattern of neurogenic atrophy at more advanced disease stages.
Conclusions: Our assay identifies a neurogenic signature in mutant muscle biopsies, even when the disease is phenotypically imperceptible.
Keywords: SOD1‐G93A; amyotrophic lateral sclerosis; graph theory; image analysis; image biomarker; motor neuron degeneration.
© 2025 British Neuropathological Society.
References
-
- J. B. Hilton, A. R. White, and P. J. Crouch, “Endogenous Cu in the Central Nervous System Fails to Satiate the Elevated Requirement for Cu in a Mutant SOD1 Mouse Model of ALS,” Metallomics 8, no. 9 (2016): 1002–1011.
-
- K. Gwinn, R. A. Corriveau, H. Mitsumoto, et al., “Amyotrophic Lateral Sclerosis: An Emerging Era of Collaborative Gene Discovery. Arendt C, ed,” PLoS One 2, no. 12 (2007): e1254.
-
- J. Czarzasta, A. Habich, T. Siwek, A. Czapliński, W. Maksymowicz, and J. Wojtkiewicz, “Stem Cells for ALS: An Overview of Possible Therapeutic Approaches,” International Journal of Developmental Neuroscience. 57 (2017): 46–55.
-
- A. Pramatarova, D. A. Figlewicz, A. Krizus, et al., “Identification of New Mutations in the Cu/Zn Superoxide Dismutase Gene of Patients With Familial Amyotrophic Lateral Sclerosis,” American Journal of Human Genetics 56, no. 3 (1995): 592–596.
-
- A. E. Renton, E. Majounie, A. Waite, et al., “A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21‐Linked ALS‐FTD,” Neuron 72, no. 2 (2011): 257–268.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
